Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
In May 2026, Lilly reported that in a late-stage trial of adults with obesity or overweight and at least one weight-related comorbidity, the highest 12 mg dose of retatrutide produced 28.3% average weight loss over 80 weeks, and more than 45% of participants lost 30% or more of their body weight
Efflux pump inhibitors for bacterial pathogens: From bench to bedside
Behavioral support In certain circumstances, behavioral counseling and support groups to address emotional eating and stress are prescribed to support your efforts
Metsera developed two formulations, each in Phase 2
This review article discusses the possible mechanisms tirzepatide may use to improve cardiovascular health
Preclinical Safety Data These side effects have not been confirmed in humans
US$ 20.17
US$ 28.63
US$ 25.68
US$ 28.17
US$ 26.20
US$ 29.32
US$ 24.08
